Reprogramming of circulatory cells in sepsis and SIRS

Abstract

Immune status is altered in patients with sepsis or non-infectious systemic inflammatory response syndrome (SIRS). Reduced ex-vivo TNF production by endotoxin-activated monocytes has been regularly reported. This observation is reminiscent of the phenomenon of endotoxin tolerance, and the term `leukocyte reprogramming' well defines this phenomenon. This review will outline that the hyporesponsiveness of circulating leukocytes is not a generalized phenomenon in sepsis and SIRS. Indeed, the nature of the insult (i.e. infectious versus non-infectious SIRS; under anesthesia [surgery] or not [trauma, burn]), the nature of the activator used to trigger leukocytes (i.e. different Toll-like receptor ligands or whole bacteria), the nature of the cell culture (i.e. isolated monocytes versus peripheral blood mononuclear cells versus whole blood assays), and the nature of the analyzed cytokines (e.g. IL-1β versus IL-1ra; TNF versus IL-10) have a profound influence on the outcome of the response.

Keywords

Sepsis SIRS leukocyte reprogramming immune response

References

Cavaillon JM , Fitting C. , Adib-Conquy M. Mechanisms of immunodysregulation in sepsis . Contrib Nephrol 2004; 144: 76—93.

Dawson CW , Ledgerwood AM , Rosenberg JC , Lucas CE Anergy and altered lymphocyte function in the injured patient. Am Surg 1982; 48: 394—401.

Angele MK , Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 2002; 6: 298—305.

Volk HD , Reinke P. , Docke WD Clinical aspects: from systemic inflammation to `immunoparalysis'. Chem Immunol 2000; 74: 167—177.

Cavaillon JM , Adrie C. , Fitting C. , Adib-Conquy M.

Endotoxin tolerance: is there a clinical relevance?

J Endotoxin Res 2003; 9: 101—107.

Zhang X. , Morrison DC Lipopolysaccharide structure—function relationship in activation versus reprogramming of mouse peritoneal macrophages. J Leukoc Biol 1993; 54: 444—450.

Geissmann F. , Jung S. , Littman DR Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71—82.

Holub M. , Kluckova Z. , Helcl M. , Prihodov J. , Rokyta R. , Beran O. Lymphocyte subset numbers depend on the bacterial origin of sepsis. Clin Microbiol Infect 2003; 9: 202—211.

Monneret G. , Debard AL , Venet F. et al. Marked elevation of human circulating CD4+CD25 + regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003; 31: 2068—2071.

10.

Fingerle G. , Pforte A. , Passlick B. , Blumenstein M. , Strobel M. , Ziegler-Heitbrock Hwl. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients . Blood 1993; 82: 3170—3176.

11.

Cummings CJ , Martin TR , Frevert CW et al. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 1999; 162: 2341—2346.

12.

Hubl W. , Wolfbauer G. , Streicher J. et al. Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome. Crit Care Med 1999; 27: 319—324.

13.

Fasano MB , Cousart S. , Neal S. , McCall CE Increased expression of the interleukin 1 receptor on blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1991; 88: 1452—1459.

14.

Furebring M. , Hakansson LD , Venge P. , Nilsson B. , Sjolin J. Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis. Crit Care 2002; 6: 363—370.

15.

Riedemann NC , Guo RF , Neff TA et al. Increased C5a receptor expression in sepsis. J Clin Invest 2002; 110: 101—108.

16.

Calvano J. , Agnese D. , Um J. et al. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 2003; 20: 415—419.

17.

Adib-Conquy M. , Moine P. , Asehnoune K. et al. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med 2003; 168: 158—164.

18.

Armstrong L. , Medford AR , Hunter KJ , Uppington KM , Millar AB Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 2004; 136: 312—319.

19.

Härter L. , Mica L. , Stocker R. , Trentz O. , Keel M. Increased expression of Toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 2004; 22: 403—409.

20.

Hershman MJ , Cheadle WG , Wellhausen SR , Davidon P. , Polk HC Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patients. Br J Surg 1990; 77: 204—207.

21.

Tschaikowsky K. , Hedwig-Geissing M. , Schiele A. , Bremer F. , Schywalsky M. , Schuttler J. Coincidence of pro- and antiinflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002; 30: 1015—1023.

22.

Fumeaux T. , Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 2002; 166: 1475—1482.

23.

Weijer S. , Lauw FN , Branger J. , van der Blink B. , van der Poll T. Diminished interferon-γ production and responsiveness after endotoxin administration to healthy humans. J Infect Dis 2002; 186: 1748—1753.

24.

Le Tulzo Y. , Pangault C. , Gacouin A. et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002 ; 18: 487—494.

25.

Hotchkiss RS , Tinsley KW , Swanson PE et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952—6963.

26.

Hotchkiss RS , Tinsley KW , Swanson PE et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 2002; 168: 2493—2500.

27.

Adrie C. , Bachelet M. , Vayssier-Taussat M. et al. Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med 2001; 164: 389—395.

28.

Keel M. , Ungethum U. , Steckholzer U. et al. Interleukin-10 counter-regulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997; 90: 3356—3363.

29.

Liacos C. , Katsaragakis S. , Konstadoulakis MM et al. Apoptosis in cells of bronchoalveolar lavage: a cellular reaction in patients who die with sepsis and respiratory failure. Crit Care Med 2001; 29: 2310—2317.

30.

Ayala A. , Herdon CD , Lehman DL , De Maso CM , Ayala CA , Chaudry IH The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock 1995; 3: 259—267.

31.

Coopersmith CM , Stromberg PE , Dunne WM et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287: 1716—1721.

32.

Grassmé H. , Kirschnek S. , Riethmueller J. et al. DC95/CD95 ligand interactions on epithelial cells in host defense Pseudomonas aeruginosa. Science 2000; 290: 527—530.

33.

Bogdan I. , Leib SL , Bergeron M. , Chow L. , Tauber MG Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis 1997; 176: 693—697.

34.

Sharshar T. , Gray F. , Lorin de la Grandmaison G. et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003 ; 362: 1799—1805.

35.

Hotchkiss RS , Tinsley KW , Swanson PE , Karl IE Endothelial cell apoptosis in sepsis. Crit Care Med 2002; 30: S225—S228.

36.

Ayala A. , Xin Xu Y. , Ayala CA et al. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 1998; 91: 1362—1372.

37.

Braun JS , Novak R. , Herzog KH , Bodner SM , Cleveland JL , Tuomanen EI Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999; 5: 298—302.

38.

Hotchkiss RS , Tinsley KW , Swanson PE et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999; 96: 14541—14546.

39.

Hotchkiss RS , Swanson PE , Knudson CM et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999; 162: 4148—4156.

40.

Wood J. , Rodrick M. , O'Mahony J. et al. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg 1984; 200: 311—320.

41.

Muret J. , Marie C. , Fitting C. , Payen D. , Cavaillon J-M. Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures. Shock 2000; 13: 169—174.

42.

Adrie C. , Adib-Conquy M. , Laurent I. et al. Successful cardiopulmonary resuscitation after cardiac arrest as a `sepsis like' syndrome. Circulation 2002 ; 106: 562—568.

43.

Cavaillon JM , Adib-Conquy M. , Fitting C. , Adrie C. , Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 2003; 35: 535—544.

44.

De AK , Kodys KM , Pellegrini J. et al. Induction of global anergy rather than inhibitory Th2 lymphokines mediates post-trauma T-cell immunodepression. Clin Immunol 2000; 96: 52—66.

45.

Puyana JC , Pellegrini JD , De AK , Kodys K. , Silva WE , Miller CL Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy. J Trauma 1998; 44: 1037—1045.

46.

McCall CE , Grosso-Wilmoth LM , LaRue K. , Guzman RN , Cousart SL Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993; 91: 853—861.

47.

Marie C. , Muret J. , Fitting C. , Losser M-R. , Payen D. , Cavaillon J-M. Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome. Blood 1998; 91: 3439—3446.

48.

Marie C. , Muret J. , Fitting C. , Payen D. , Cavaillon J-M. IL-1 receptor antagonist production during infectious and noninfectious systemic inflammatory response syndrome. Crit Care Med 2000; 28: 2277—2283.

49.

Schultz MJ , Olszyna DP , de Jonge E. , Verbon A. , van Deventer Sjh , van der Poll T. Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin. J Infect Dis 2000; 182: 1264—1267.

50.

Muñoz C. , Carlet J. , Fitting C. , Misset B. , Bleriot JP , Cavaillon J-M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747—1754.

51.

Van Deuren M. , Van Der Ven-Jongekrijg H. , Demacker Pnm et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994; 169: 157—161.

52.

Randow F. , Syrbe U. , Meisel C. et al. Mechanism of endotoxin desensitization: involvement of interleukin-10 and transforming growth factor-β. J Exp Med 1995; 181: 1887—1892.

53.

Ertel W. , Keel M. , Neidhardt R. et al. Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood 1997; 89: 1612—1620.

54.

Spolarics Z. , Siddiqi M. , Siegel J. et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients . Crit Care Med 2003; 31: 1722—1729.

55.

Fumeaux T. , Dufour J. , Stern S. , Pugin J. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 2004; 30: 2028—2037.

56.

Granowitz EV , Porat R. , Mier JW et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans . J Immunol 1993; 151: 1637—1645.

57.

Marchant A. , Alegre M. , Hakim A. et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15: 265—272.

58.

Keel M. , Schregenberger N. , Steckholzer U. et al. Endotoxin tolerance after severe injury and its regulatory mechanisms . J Trauma 1996; 41: 430—437.

59.

Döcke WD , Randow F. , Syrbe U. et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 1997; 3: 678—681.

60.

Majetschak M. , Flach R. , Kreuzfelder E. et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med 1999; 27: 313—318.

61.

Cabié A. , Fitting C. , Farkas J-C. et al. Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine 1992; 4: 576—580.

62.

Hensler T. , Hecker H. , Heeg K. et al. Distinct mechanism of immunosuppression as a consequence of major surgery. Infect Immun 1997; 65: 2283—2291.

63.

van Deuren M. , Twickler TB , de Waal Malefyt MC et al. Elective orthopedic surgery, a model for the study of cytokine activation and regulation. Cytokine 1998; 10: 897—903.

64.

Cavaillon J-M. `Septic plasma': an immunosuppressive milieu . Am J Respir Crit Care Med 2002; 166: 1417—1418.

65.

Cavaillon J-M. , Adib-Conquy M. , Cloëz-Tayarani I. , Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res 2001 ; 7: 85—93.

66.

Haupt W. , Zirngibl H. , Riese J. , Stehr A. , Linde HJ , Hohenberger W. Depression of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 production: a reaction to the initial systemic hyperactivation in septic shock . J Invest Surg 1997; 10: 349—355.

67.

Muñoz C. , Misset B. , Fitting C. , Bleriot JP , Carlet J. , Cavaillon J-M. Dissociation between plasma and monocyte-associated cytokines during sepsis . Eur J Immunol 1991; 21: 2177—2184.

68.

Weiss M. , Fischer G. , Barth E. et al. Dissociation of LPS-induced monocytic ex vivo production of granulocyte colony-stimulating factor (G-CSF) and TNF-alpha in patients with septic shock. Cytokine 2001; 13: 51—54.

69.

Maxime V. , Fitting C. , Annane D. , Cavaillon JM Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J Infect Dis 2005; 191: 138—144.

70.

Rigato O. , Salomao R. Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 2003; 19: 113—116.

71.

Kreutz M. , Ackerman U. , Hauschildt S. et al. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphylococcus aureus in human monocytes. Immunology 1997 ; 92: 396—401.

72.

Crabtree TD , Jin L. , Raymond DP et al. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun 2001; 69: 2123—2129.

73.

Lehner MD , Morath S. , Michelsen KS , Schumann RR , Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators . J Immunol 2001; 166: 5161—5167.

74.

Cavaillon J-M. , Pitton C. , Fitting C. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ. J Endotoxin Res 1994; 1: 21—29.

75.

Nose M. , Uzawa A. , Nomura M. et al. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432. Cell Immunol 1998; 188: 97—104.

76.

Vogel SN , Kaufman EN , Tate MD , Neta R. Recombinant IL-1α and TNF-α synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 1988; 56: 2650—2657.

77.

Ferlito M. , Romanenko OG , Ashton S. , Squadrito F. , Halushka PV , Cook JA Effect of crosstolerance between endotoxin and TNF-α or IL-1β on cellular signaling and mediator production. J Leukoc Biol 2001; 70: 821—829.

78.

Dobrovolskaia MA , Medvedev AE , Thomas KE et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR `homotolerance' versus `heterotolerance' on NF-kappa B signaling pathway components. J Immunol 2003; 170: 508—519.

79.

Fitting C. , Dhawan S. , Cavaillon J-M. Compartmentalisation of endotoxin tolerance. J Infect Dis 2004; 189: 1295—1303.

80.

Cavaillon J-M. , Muñoz C. , Marty C. et al. Cytokine production by monocytes from patients with sepsis syndrome and by endotoxin-tolerant monocytes. In: Levin J, Alving CR, Munford RS, Stütz PL. (eds) Bacterial Endotoxin: Recognition and Effector Mechanisms. Excerpta Medica, 1993; 275—284.

81.

Astiz ME , Saha DC , Brooks K. , Carpati CM , Rackow EC Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ Shock 1993; 39: 194—198.

82.

Wilhelm W. , Grundmann U. , Rensing H. et al. Monocyte deactivation in severe human sepsis or following cardiopulmonary bypass. Shock 2002; 17: 354—360.

83.

Mitov IG , Kropec A. , Benzing A. et al. Differential cytokine production in stimulated blood cultures from intensive care patients with bacterial infections. Infection 1997; 25: 206—212.

84.

Lembo A. , Kalis C. , Kirschning C. et al. Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect Immun 2003; 71: 6058—6062.

85.

De AK , Kodys K. , Puyana JC , Fudem G. , Savoie P. , Miller-Graziano CL Elevated IL-8 production by trauma patients' monocytes is associated with elevated secretion of TNF alpha. Shock 1995 ; 4: 171—177.

86.

Ziegler-Heitbrock Hwl , Wedel A. , Schraut W. et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers . J Biol Chem 1994; 269: 17001—17004.

87.

Adib-Conquy M. , Adrie C. , Moine P. et al. NF-κB expression in mononuclear cells of septic patients resembles that observed in LPS-tolerance. Am J Respir Crit Care Med 2000; 162: 1877—1883.

88.

Kobayashi K. , Hernandez LD , Galan JE , Janeway Caj , Medzhitov R. , Flavell RA IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191—202.

89.

Escoll P. , del Fresno C. , Garcia L. et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003; 311: 465—472.

90.

Fukao T. , Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003; 24: 358—363.

91.

Learn CA , Boger MS , Li L. , McCall CE The phosphatidylinositol 3 kinase pathway selectively controls sIL-1ra not interleukin-1β production in the septic leukocytes. J Biol Chem 2001; 276: 20234—20239.

92.

Zhang G. , Ghosh S. Negative regulation of Toll-like receptor-mediated signaling by Tollip. J Biol Chem 2002; 277: 7059—7065.

93.

Nakagawa R. , Naka T. , Tsutsui H. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17: 677—687.

94.

Janssens S. , Burns K. , Tschopp J. , Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr Biol 2002; 12: 467—471.

95.

Brint EK , Xu D. , Liu H. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004; 5: 373—379.

96.

Wald D. , Qin J. , Zhao Z. et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4: 920—927.

97.

Munford RS , Pugin J. Normal response to injury prevent systemic inflammation and can be immunosuppressive . Am J Respir Crit Care Med 2001; 163: 316—321.

98.

Bone RC , Grodzin CJ , Balk RA Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 121: 235—243.

99.

O'Sullivan ST , Lederer JA , Horgan AF , Chin Dhl , Mannick JA , Rodrick ML Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222: 482—492.

100.

Ertel W. , Morrison MH , Ayala A. , Dean R. , Chaudry IH Interferon-γ attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 1992; 111: 177—187.

101.

Hershman MJ , Polk Hcj , Pietsch JD , Shields RE , Wellhausen SR , Sonnenfeld G. Modulation of infection by gamma interferon treatment following trauma. Infect Immun 1998 ; 56: 2412—2416.

102.

Benjamim CF , Hogaboam CM , Lukacs NW , Kunkel SL Septic mice are susceptible to pulmonary aspergillosis . Am J Pathol 2003; 163: 2605—2617.

103.

Murphey ED , Lin CY , McGuire RW , Toliver-Kinsky T. , Herndon DN , Sherwood ER Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 2004; 21: 415—425.

104.

Baker C. , Miller C. , Trunkey D. Predicting fatal sepsis in burn patients. J Trauma 1979; 19: 641—648.

105.

Keane R. , Birmingham W. , Shatney C. , Winchurch R. , Munster A. Prediction of sepsis in the multitraumatic patients by assays of lymphocyte responsiveness. Surg Gynecol Obstet 1983; 156: 163—167.

106.

Levy EM , Alharbi SA , Grindlinger G. , Black PH Changes in mitogen responsiveness lymphocytes subsets after traumatic injury: relation to development of sepsis. Clin Immunol Immunopathol 1984; 32: 224—233.

107.

Heagy W. , Hansen C. , Nieman K. et al. Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify `septic' intensive care unit patients . Shock 2000; 14: 271—277.

108.

Hensler T. , Heidecke CD , Hecker H. et al. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 1998; 161: 2655—2659.

109.

van den Berk Jmm , Oldenburger Rhj , van den Berg AP et al. Low HLA DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation 1997; 63: 1846—1848.

110.

Lekkou A. , Karakantza M. , Mouzaki A. , Kalfarentzos F. , Gogos CA Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11: 161—167.

111.

Flohé S. , Lendemans S. , Selbach C. et al. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 2003; 31: 2462—2469.

112.

Dries DJ , Jurkovich GJ , Maier RV et al. Effect of interferon-gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial . Arch Surg 1994; 129: 1031—1041.